Bosutinib for the treatment of chronic myeloid leukemia in chronic phase. [electronic resource]
Producer: 20120612Description: 177-88 p. digitalISSN:- 1699-3993
- Aniline Compounds -- metabolism
- Animals
- Benzamides
- Clinical Trials as Topic
- Drug Evaluation, Preclinical
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Nitriles -- metabolism
- Piperazines -- adverse effects
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- adverse effects
- Quinolines -- metabolism
- Treatment Failure
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.